"I know there are significant opportunities for the development of innovative neuro-engineering therapies," Barchi said. "
This initiative is being led by
"This is a bold experiment, designed to create an enhanced, faculty-driven path for the formation of partnerships with industry with the goal of translating research advances into products and therapies that improve our healthcare," Kohn said.
The mission of the
RUNEG will foster collaborative and interdisciplinary research efforts to enhance understanding of the multidisciplinary field of neural engineering, devices, and cellular therapies to enable the translation of technology from bench to bedside. The group will seek active participation from the members of the biomedical device and pharmaceutical industries to accelerate the transfer and commercialization of inventions and technologies into clinically useful products and therapies through streamlined steps.
An important objective of RUNEG is to provide cutting-edge training and education, in the form of seminars and a yearly workshop, delivered by world-class investigators within RUNEG as well as invited speakers who lead their fields. These events will enhance learning, communication, and collaboration for neuroscientists in industry and academia.
More information, including a list of participating scientists and links to their websites, is posted on the RUNEG website.
Industry inquiries can be directed to Prof. Kohn, email@example.com, and
Read the full story at http://www.prweb.com/releases/2014/05/prweb11811457.htm
Most Popular Stories
- National Retail Federation Reduces Sales Forecast
- Long-term Strengths Emerge in U.S. Economy
- Honda' s Accord Plug-in Hybrid Is a Fuel Miser
- Xavier Gutierrez Appointed to Bank Board
- Amazon Fire Phone Improves on Familiar: Review
- Self-Induced Abortions Rise After Texas Closes Clinics
- Naya Rivera and Ryan Dorsey Are Married
- Comic-Con Festival Kicks Off in San Diego
- Marco Rubio Swings Back to the Right
- Social Media Startups That Pay You to Post